News
VACHU
12.80
0.00%
0.00
Xlife Sciences publishes 2025 annual report
PUBT · 4d ago
NASDAQ TRADE HALT <VACH.O> VOLATILITY TRADING PAUSE AT 09:32 AM
Reuters · 03/19 13:32
Voyager Acquisition shareholders approve Veraxa Biotech AG merger with 99.67% redemptions
Reuters · 03/18 20:07
BUZZ-U.S. STOCKS ON THE MOVE-PayPay Corp, Ulta Beauty, InMode
Reuters · 03/13 13:31
BUZZ-U.S. STOCKS ON THE MOVE-Adobe, PAR Technology, Klarna Group
Reuters · 03/13 11:47
Voyager Acquisition approves Veraxa deal after 100% share redemption
Seeking Alpha · 03/13 11:39
BUZZ-Voyager Acquisition rises as shareholders back VERAXA Biotech merger
Reuters · 03/13 10:23
VOYAGER ACQUISITION CORP II - TO APPLY TO HAVE OUR UNITS LISTED ON NASDAQ GLOBAL MARKET, OR NASDAQ, UNDER THE SYMBOL "VAIIU"- SEC FILING
Reuters · 03/13 10:04
VOYAGER ACQUISITION CORPORATION ANNOUNCES APPROVAL OF ITS BUSINESS COMBINATION WITH VERAXA BIOTECH AG
Reuters · 03/13 10:00
Voyager Acquisition says 100% of Class A shares were redeemed in VERAXA Biotech deal
Reuters · 03/11 10:01
VOYAGER ACQUISITION CORP - REDEMPTIONS REPRESENT 99.67% OF TOTAL CLASS A SHARES OUTSTANDING
Reuters · 03/11 10:00
Based on the provided financial report articles, I generated the title for the article:
"VACHU, Inc. (0002006815) - 2025 Financial Report: IPO, Private Placement, and Warrant Information"
Please note that the title may not be exact, as the provided text is a financial report and may not contain a specific title.
Press release · 03/11 04:00
Voyager Acquisition FY2025 net income rose 117% to USD 8.99 million
Reuters · 03/10 21:00
VERAXA shareholders approve merger with Voyager Acquisition Corp. for NASDAQ listing under VRXA
Reuters · 03/03 06:01
VERAXA Biotech Shareholders Approve Merger to List on Nasdaq as VRXA
Reuters · 03/03 06:01
VERAXA Biotech Shareholders Approve Merger With Voyager Acquisition Corp
Reuters · 02/27 21:46
VOYAGER ACQUISITION CORP - MERGER CONSIDERATION INCREASED TO $1.35 BLN - SEC FILING
Reuters · 02/03 12:06
Voyager Acquisition Corp. Raises Veraxa Deal Value to $1.35 Billion
Reuters · 02/03 12:05
Xlife Sciences AG Advances VERAXA Biotech NASDAQ Listing After SEC Filing Update
Reuters · 11/28/2025 12:13
Voyager Acquisition Corp. Extends Veraxa Deal Deadline and Removes Termination Fee
Reuters · 10/21/2025 10:04
More
Webull provides a variety of real-time VACHU stock news. You can receive the latest news about Voyager Acqsn through multiple platforms. This information may help you make smarter investment decisions.
About VACHU
Voyager Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It may pursue an initial business combination in any business or industry. The Company has not conducted any operations and has generated no revenues.